Christopher D. Pfeiffer, M.D., M.H.S. (he/him)

  • Associate Professor of Medicine, Division of Infectious Diseases, School of Medicine
  • VA Portland Health Care System

Biography

Since 2011, Dr. Pfeiffer has served as the Hospital Epidemiologist at the VA Portland Health Care System (VAPORHCS) and as an Infectious Diseases (ID) physician, rounding on both General and Transplant ID consult services at VAPORHCS and Oregon Health & Science University (OHSU).   Since 2018, he also serves as the Chief for the VAPORHCS ID section.

In 2012, he began what is a fruitful ongoing collaboration with the Oregon Health Authority (OHA) by becoming the Medical Director for our Drug-Resistant Organism Prevention and Coordinated Regional Epidemiology (DROP-CRE) Network. The primary goals of DROP-CRE Network, which is funded through OHA by CDC, are to prevent, detect, and control the spread of multidrug-resistant organisms (MDROs) with a focus on carbapenem-resistant Enterobacteriaceae (CRE) and more recently C. auris in Oregon. 

Dr. Pfeiffer has become involved in many multicenter collaborations within the VA system, and he was the Principal Investigator of a CDC-funded project entitled, "Preventing Spread of Carbapenem-Resistant Enterobacteriaciae (CRE) among Veterans through an Automated Tracking System". This project culminated in the development and implementation of a novel electronic system now called VA Bug Alert (VABA) which alerts local infection prevention teams when patients with a history of MDROs such as CRE & C. auris are admitted to any VA facility. 

Dr. Pfeiffer enjoys spending time outdoors with his family walking, hiking, biking, playing tennis when he's not injured, and gardening (a.k.a. cleaning the yard).

Education and training

  • Degrees

    • M.D., 2003, The Ohio State University
    • M.H.S., 2010, Duke University
  • Residency

    • Internal medicine, University of Wisconsin (Madison), 2006
  • Fellowship

    • Infectious diseases, Duke University, 2010
    • Medical Microbiology, Duke University, 2011
  • Certifications

    • American Board of Internal Medicine (internal medicine), 2006

Memberships and associations:

  • Infectious Diseases Society of America
  • Society for Healthcare Epidemiology of America

Areas of interest

  • Healthcare-associated infection, multidrug-resistant organisms (MDROs), Hospital Epidemiology
  • Infections in the Immunocompromised Host, Hospital Epidemiology.

Publications

Elsevier pure profile

Selected publications

  • Pfeiffer CD, Fine JP, Safdar N. Diagnosis of Invasive Aspergillosis Using a Galactomannan Assay: a Meta-Analysis. Clinical Infectious Diseases. 2006 May 15;42: 1417-27.
  • Pfeiffer CD, Garcia-Effron G, Zaas AK, Perfect JP, Perlin DA, Alexander BD. Breakthrough Invasive Candidiasis in Patients on Micafungin;Journal of Clinical Microbiology. 2010 Jul;48:2373-80.
  • Pfeiffer CD, Samsa GP, Schell WA, Reller LB, Perfect JR, Alexander BD. Quantitation of Candida CFU in initial positive blood cultures. Journal of Clinical Microbiology. 2011 Aug;49:2879-83.
  • Alexander BD, Johnson MD, Pfeiffer CD, Jiménez-Ortigosa C, Catania J, Booker R, Castanheira M, Messer SA, Perlin DS, Pfaller MA. Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations. Clin Infect Dis. 2013 Jun;56(12):1724-32. doi: 10.1093/cid/cit136. Epub 2013 Mar 13.PMID: 23487382.
  • Pfeiffer CD, Cunningham MC, Poissant T, Furuno JP, Townes JM, Leitz A, Thomas A, Buser GM, Arao RF, Beldavs ZG. Establishment of a Statewide Network for Carbapenem-Resistant Enterobacteriaceae Prevention in a Low Incidence Region. Infect Control Hosp Epidemiol. 2014 Apr;35(4):356-61. doi: 10.1086/675605. PMID: 24602939.
  • Pfeiffer CD and Beldavs ZG. Commentary: Much to Do about Carbapenem-Resistant Enterobacteriaceae: Why Supplementing Surveillance May Be the Key to Stopping Spread. Infect Control Hosp Epidemiol. Infect Control Hosp Epidemiol. 2014 Aug;35(8):984-5. doi: 10.1086/677158. Epub 2014 Jun 20. PMID:25026613.
  • Morey KE, Vega R, Cassidy PM, Buser GL, Rayar JK, Myers JA, Weissman SJ, Beldavs ZG, Pfeiffer CD. Evaluation of the Carba NP Test in Oregon, 2013. Antimicrob Agents Chemother. 2016 Dec 27;61(1). pii: e03005-15. doi: 10.1128/AAC.03005-15. Print 2017 Jan. PMID: 27795386.
  • Guidance for Control of Carbapenem-resistant Enterobacteriaceae (CRE): 2016 Oregon Toolkit. The Oregon Health Authority, Acute and Communicable Disease Prevention Program. Published December, 2015.